人参
小RNA
小桶
生物
计算生物学
基因
转录组
传统医学
生物信息学
遗传学
基因表达
医学
病理
替代医学
作者
Yingfang Wang,Mengyuan Peng,Yanlin Chen,Wenjuan Wang,Zhihua He,Zemin Yang,Zhiyun Lin,Mengjuan Gong,Yong-Qin Yin,Yu Zeng
出处
期刊:Planta Medica
[Thieme Medical Publishers (Germany)]
日期:2019-08-21
卷期号:85 (14/15): 1168-1176
被引量:14
摘要
Abstract Panax ginseng has been widely and effectively used as medicine for thousands of years. However, only limited studies have been conducted to date on ginseng miRNAs. In the present study, we collected 3 ginseng samples from the Changbai Mountain in China. Small RNA libraries were constructed and sequenced on the Illumina HiSeq platform. Sequencing analyses identified 3798 miRNAs, including 298 known miRNAs and 3500 potentially novel miRNAs. The miR166, miR159, and miR396 families were among the most highly expressed miRNAs in all libraries. The results of miRNA expression analyses were validated by qRT-PCR. Target gene prediction through computational and pathway annotation analyses revealed that the primary pathways were related to plant development, including metabolic processes and single-organism processes. It has been reported that plant miRNAs might be one of the hidden bioactive ingredients in medicinal plants. Based on the combined use of RNAhybrid, Miranda, and TargetScan software, a total of 50,992 potential human genes were predicted as the putative targets of 2868 miRNAs. Interestingly, the enriched KEGG pathways were associated with some human diseases, especially cancer, immune system diseases, and neurological disorders, and this could support the clinical use of ginseng. However, the human targets of ginseng miRNAs should be confirmed by further experimental validation. Our results provided valuable insight into ginseng miRNAs and the putative roles of these miRNAs.
科研通智能强力驱动
Strongly Powered by AbleSci AI